Preventing obesity-related liver tumorigenesis by inhibiting the IGF/IGF-1R axis, alleviating hyperinsulinemia, and reducing chronic inflammation. This evidence concerns the gene IGF1 and obesity due to melanocortin 4 receptor deficiency.